Inserm
Paris, France · 22 authors
Inserm (Paris, France): 22 authors and 12 papers in the de novo peptide sequencing catalog.
Papers (12)
- Interferon-α promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic β-cells (2025, Nature Communications)
- MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer (2024, Nature Communications)
- The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides (2023, Cancer Immunology Research)
- Venomics survey of six myrmicine ants provides insights into the molecular and structural diversity of their peptide toxins (2022, Insect Biochemistry and Molecular Biology)
- MARS: Improved De Novo Peptide Candidate Selection for Non-Canonical Antigen Target Discovery in Cancer (2022, Research Square)
- The shell matrix of the european thorny oyster, Spondylus gaederopus: microstructural and molecular characterization (2020, Journal of Structural Biology)
- Venom Peptide Repertoire of the European Myrmicine Ant Manica rubida: Identification of Insecticidal Toxins (2020, Journal of Proteome Research)
- Identification of potential chemosignals in the European water vole Arvicola terrestris (2019, Scientific Reports)
- Deciphering the Molecular Diversity of an Ant Venom Peptidome through a Venomics Approach (2018, Journal of Proteome Research)
- Can Two-Dimensional IR-ECD Mass Spectrometry Improve Peptide de Novo Sequencing? (2018, Analytical Chemistry)
- Disruption of SMIM1 causes the Vel− blood type (2013, EMBO Molecular Medicine)
- Proteomic studies highlight outer‐membrane proteins related to biofilm development in the marine bacterium Pseudoalteromonas sp. D41 (2012, PROTEOMICS)